HomepageIC7 • FRA
add
ICU Medical Inc
Vorige slotkoers
€ 115,00
Dag-range
€ 114,00 - € 114,00
Jaar-range
€ 108,00 - € 170,00
Beurswaarde
3,33 mld. USD
Koers/winst
-
Dividendrendement
-
Primaire beurs
NASDAQ
Marktnieuws
Financiële informatie
Resultatenrekening
Opbrengst
Netto inkomsten
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Opbrengst | 604,70 mln. | 6,71% |
Bedrijfskosten | 180,52 mln. | 0,57% |
Netto inkomsten | -15,48 mln. | 60,79% |
Netto winstmarge | -2,56 | 63,27% |
Winst per aandeel | 1,72 | 79,17% |
EBITDA | 79,03 mln. | 28,98% |
Effectief belastingtarief | -41,90% | — |
Balans
Totale activa
Totale passiva
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Contanten en kortetermijnbeleggingen | 298,11 mln. | 8,15% |
Totale activa | 4,18 mld. | -2,42% |
Totale passiva | 2,20 mld. | -1,07% |
Totaal aandelenvermogen | 1,99 mld. | — |
Uitstaande aandelen | 24,61 mln. | — |
Koers-boekwaardeverhouding | 1,42 | — |
Rendement op activa | 1,76% | — |
Rendement op kapitaal | 2,06% | — |
Kasstroom
Nettomutatie in liquide middelen
(USD) | mrt 2025info | Wijziging j-o-j |
---|---|---|
Netto inkomsten | -15,48 mln. | 60,79% |
Operationele kasstroom | 51,33 mln. | 12,09% |
Kasstroom uit beleggingen | -16,81 mln. | 5,88% |
Kasstroom uit financiering | -56,34 mln. | -109,86% |
Nettomutatie in liquide middelen | -18,86 mln. | -573,88% |
Vrije kasstroom | 42,73 mln. | 0,68% |
Over
ICU Medical, Inc. is a medical technology company based in San Clemente, California. ICU Medical products are designed to prevent bloodstream infections and protect healthcare workers from exposure to infectious diseases or hazardous drugs. ICU Medical product line includes intravenous therapy (IV) products, pumps, needle-free vascular access devices, custom infusion sets, closed system hazardous drug handling devices and systems, sensor catheters, needle-free closed blood sampling systems, and hemodynamic monitoring systems.
ICU Medical products are designed to prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. In addition, the company's IV medication compounding and delivery products are designed to improve medication and dosing accuracy and improve clinical workflows. In 2014 ICU Medical was named one of the 100 Most Trustworthy Companies in America by Forbes Magazine. Wikipedia
CEO
Opgericht
1984
Hoofdvestiging
Website
Werknemers
15.000